Eunice Guzman
Infectious Disease · Myrtle Beach, SCNPI 1043508708
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Gilead at 59.5% of the total. Reporting peaked in 2022 at $5,581 and has fallen 95.7% since, to $242 in 2025. Among infectious disease clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $53.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- Viiv Healthcare Company$3K
- Indivior Inc.$139
- Theratechnologies Inc.$138
- Johnson & Johnson$130
- AbbVie$120
- plus $341 from 9 others
What the payments were for
- Consulting fees$4,76045%
- Travel & lodging$1,03410%
- Food & beverage$4,67445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 67 | $6,226 |
| Viiv Healthcare Company | 85 | $3,374 |
| Indivior Inc. | 2 | $139 |
| Theratechnologies Inc. | 6 | $138 |
| Johnson & Johnson(2 entities) | 8 | $130 |
| AbbVie | 6 | $120 |
| Insmed, Inc. | 5 | $89 |
| GSK | 3 | $56 |
| Merck | 3 | $44 |
| Pfizer | 3 | $44 |
| Janssen Scientific Affairs, LLC | 2 | $35 |
| AstraZeneca(2 entities) | 2 | $29 |
| Alkermes, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Neuronetics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,468 in reported general payments places this provider in the 90th percentile of 102 infectious disease providers in South Carolina.
Other infectious disease in Myrtle Beach
- Timothy HenkelHilton Head Island$1.8M
- Toby FugateCharleston$136K
- John McKinnonCharleston$85K
- John SchrankGreenville$74K
- Rishika MotianiFlorence$43K
- John GnannCharleston$39K
- John SamiesOrangeburg$18K
- Akinwale OlatosiCamden$17K
- Robert BallNorth Charleston$14K
- Scott CurryCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.